共 50 条
- [21] EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMAS LANCET, 1977, 2 (8028): : 87 - 87
- [22] VP 16-213 (VP) AND CYCLOPHOSPHAMIDE (CTX) IN THE TREATMENT OF REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) WITH MONOCYTIC FEATURES PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 439 - 439
- [24] COMBINATION THERAPY WITH AMSA AND ETOPOSIDE (VP 16-213) IN REFRACTORY ACUTE MYELOBLASTIC-LEUKEMIA - A PHASE-I STUDY ONKOLOGIE, 1984, 7 (04): : 214 - 216
- [25] EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN TREATMENT OF SOLID TUMORS LANCET, 1977, 2 (8033): : 362 - 362
- [26] COMBINATION CHRONO-CHEMOTHERAPY OF L1210 LEUKEMIC MICE ANATOMICAL RECORD, 1978, 190 (02): : 533 - 533
- [27] METABOLIC-ACTIVATION OF THE ANTITUMOR AGENT VP 16-213 PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 308 - 308
- [28] EPIPODOPHYLLOTOXIN (VP 16-213) IN TREATMENT OF DIFFUSE HISTIOCYTIC LYMPHOMA SOUTH AFRICAN MEDICAL JOURNAL, 1975, 49 (13): : 483 - 485
- [29] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE (VP 16-213) EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (10): : 1149 - 1155